Martha Townsend

Martha Townsend is an accomplished professional in the diagnostics and pharmaceutical industries, currently serving as Global Director of Diagnostic Marketing at Cytokinetics since April 2022, focusing on strategic planning for Omecamtiv mecarbil and diagnostic testing. With extensive experience, Martha founded Market Ready Rx, Inc. in 2006, providing consultancy services for market entry in Companion Diagnostics, Molecular PCR systems, and Next Generation Sequencing. Additional roles include Principal at Halteres Associates, Acting Marketing Director at Diagnostic Biosystems, and various positions at Dako and Chiron Corporation, where significant contributions to sales, marketing, and product management were made. Martha holds a Bachelor of Science in Biology from Loyola Marymount University and a Certificate in Medical Marketing from UCLA Anderson School of Management.